Our anti-CDH17 Mab D2101 radiolabeled with 111In exhibited high levels of tumor uptake and low background levels in the biodistribution and SPECT/CT studies in a CDH17-positive gastric cancer mouse model. This evidence concerns the gene CDH17 and neoplasm.